Last reviewed · How we verify

NCT04251390

Initial Outcomes of Robotic Lower Extremity Exoskeleton Use by a Non-ambulatory Child With CP

Completed Last updated 8 February 2023
What this trial tests

trial testing trexo Home in Cerebral Palsy in 1 participant. Completed in 4 February 2021.

Timeline
6 December 2019
Primary endpoint
15 March 2020
4 February 2021

Quick facts

Lead sponsorUniversity of Calgary
StatusCompleted
Study typeOBSERVATIONAL
Enrollment1
Start date6 December 2019
Primary completion15 March 2020
Estimated completion4 February 2021
Sites1 location across Canada

Drugs / interventions tested

Conditions studied

Sponsor

University of Calgary

Who can join

Adults 7 to 8, female only, with Cerebral Palsy. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

There are very few evidence-based interventions for children with cerebral palsy who cannot walk. The Trexo-Home is a device that is newly available for rent by families, but its impact is unknown. By tracking and recording various outcome measures throughout this project, the investigators hope to inform future larger scale controlled studies.

Publications & conference data

1 peer-reviewed publication reference this trial (live from Europe PMC):

  1. Robotic lower extremity exoskeleton use in a non-ambulatory child with cerebral palsy: a case study.
    Diot CM, Thomas RL, Raess L, Wrightson JG, et al · · 2023 · cited 13× · PMID 33539714 · DOI 10.1080/17483107.2021.1878296

Verify or expand the search:

Other recruiting trials for Cerebral Palsy

Currently open trials in the same condition.

Other University of Calgary trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04251390.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing